Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
苦逼的科研汪完成签到,获得积分10
1秒前
Hannah完成签到,获得积分10
2秒前
小心超人发布了新的文献求助10
2秒前
zhuding1978完成签到,获得积分10
2秒前
kk发布了新的文献求助10
2秒前
yuzhuoWng发布了新的文献求助10
2秒前
sewing完成签到,获得积分10
2秒前
2秒前
arniu2008应助科研通管家采纳,获得20
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
3秒前
大模型应助科研通管家采纳,获得10
3秒前
hhh完成签到,获得积分10
3秒前
Jasper应助科研通管家采纳,获得10
3秒前
打打应助科研通管家采纳,获得10
3秒前
传奇3应助科研通管家采纳,获得10
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
iitj应助科研通管家采纳,获得20
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
Orange应助科研通管家采纳,获得10
4秒前
完美世界应助科研通管家采纳,获得10
4秒前
4秒前
玖a完成签到,获得积分10
4秒前
4秒前
mmm完成签到,获得积分10
4秒前
KINGAZX完成签到 ,获得积分10
5秒前
科研狗应助Feegood采纳,获得50
6秒前
will完成签到,获得积分10
6秒前
雪小岳完成签到,获得积分10
6秒前
屋顶橙子味完成签到,获得积分10
6秒前
小白龙完成签到 ,获得积分10
7秒前
梦溪完成签到,获得积分10
7秒前
刘刘发布了新的文献求助10
7秒前
yskm发布了新的文献求助10
7秒前
桐桐应助zhang采纳,获得10
8秒前
瀚子发布了新的文献求助10
8秒前
Godzilla完成签到,获得积分10
8秒前
8秒前
9秒前
CFD应助sun采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
Merrill's Atlas of Radiographic Positioning and Procedures - 3-Volume Set, 16th Edition 2000
Matrix Methods in Data Mining and Pattern Recognition 540
Interactions of Vowel Quality and Prosody in East Slavic 500
Vander's Renal Physiology第10版 500
Materials Informatics Molecules, Crystals and Beyond A volume in Acta Materialia Book Series 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7066214
求助须知:如何正确求助?哪些是违规求助? 8727591
关于积分的说明 18468996
捐赠科研通 6596744
什么是DOI,文献DOI怎么找? 3125890
关于科研通互助平台的介绍 2221713
邀请新用户注册赠送积分活动 2101464